UPSTATE NEW YORK TRANSPLANT SERVICES INC (EIN 161172453) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1981

Legal Domicile

Principal Officer

KEVIN GRAMLICH

Phone

7165294300

Tax Period

2024-01-01 to 2024-12-31

UPSTATE NEW YORK TRANSPLANT SERVICES INC, founded in 1981, is a mid-sized nonprofit that reported $40.4M in total revenue in fiscal year 2024.

Mission

TO IDENTIFY, AUGMENT, AND PROCURE TRANSPLANT ORGANS, BLOOD, AND EYES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $199,453

Program Service Revenue $40,166,732

Investment Income $55,075

Other Revenue $-7,878

TOTAL REVENUE $40,413,382

Expense Breakdown

Grants Paid $0

Salaries & Benefits $16,769,481

Fundraising Expenses $89,416

Program Expenses $33,994,693

Other Expenses $22,676,143

TOTAL EXPENSES $39,445,624

Year-over-Year Comparison

	2024	2023	Change
Revenue	$40,413,382	$37,750,254	+0.1%
Expenses	$39,445,624	$37,144,770	+0.1%
Net Income	$967,758	$605,484	+0.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

300

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,313,010

Total Directors

Key Employees

$423,926

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RICHARD A GRIMM III	CHAIR	1.00	Officer Director	$0	$0	$0
JOHN G SCHMIDT JR	VICE CHAIR	1.00	Officer Director	$0	$0	$0
MICHAEL LARRY	TREASURER	1.00	Officer Director	$0	$0	$0
DAVID CARLSON	SECRETARY	1.00	Officer Director	$0	$0	$0
JOANNE BECKER MD	DIRECTOR	1.00	Director	$0	$0	$0
SAMUEL CLOUD MD	DIRECTOR	1.00	Director	$0	$0	$0
CHRISTOPHER COLLINS THRU 824	DIRECTOR	1.00	Director	$0	$0	$0
JOHN DUERR	DIRECTOR	1.00	Director	$0	$0	$0
AMILCAR HILL	DIRECTOR	1.00	Director	$0	$0	$0
BETH HUGHES	DIRECTOR	1.00	Director	$0	$0	$0
AMY NASH	DIRECTOR	1.00	Director	$0	$0	$0
THOMAS NOONAN	DIRECTOR	1.00	Director	$0	$0	$0
RONALD RACCUIA	DIRECTOR	1.00	Director	$0	$0	$0
CHRISTINE STOLZENBURG	DIRECTOR	1.00	Director	$0	$0	$0
MARK SIMON	PRESIDENT (THROUGH 12/31/24)	36.00	Officer	$916,849	$135,683	$1,052,532
FREDERICK GILL	CFO	39.00	Officer	$203,940	$56,538	$260,478
KEVIN GRAMLICH	CEO (PRESIDENT & CEO EFF. 1/1/25)	40.00	Key Emp	$362,758	$61,168	$423,926
SARAH DIINA	SENIOR DIRECTOR OF MARKETING	40.00	Highest	$139,557	$19,756	$159,313
AALIYAH BALL	TISSUE RECOVERY TEAM LEADER	40.00	Highest	$180,110	$1,254	$181,364
MATTHEW MOWREY	SENIOR DIRECTOR OF BLOOD OPERATION	40.00	Highest	$153,503	$21,518	$175,021
MARY PFEIFFER	SENIOR DIRECTOR OF EYE AND TISSUE	40.00	Highest	$149,732	$20,346	$170,078
KARA YOUNG	TISSUE RECOVERY TEAM LEADER	40.00	Highest	$181,515	$5,571	$187,086
ROXANE HUYLER	FORMER SENIOR VP OF HUMAN RESOURCE	0.00		$113,997	$0	$113,997

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$40,413,382	$39,445,624	$39,911,635	$967,758
2023	$37,750,254	$37,144,770	$36,402,335	$605,484
2022	$33,799,199	$35,351,760	$36,040,727	$-1,552,561
2021	$34,653,271	$33,560,387	$36,419,881	$1,092,884
2020	$32,055,147	$31,302,254	$36,879,412	$752,893
2019	$31,497,553	$30,970,844	$36,294,158	$526,709
2018	$29,090,446	$28,152,416	$33,691,637	$938,030

UPSTATE NEW YORK TRANSPLANT SERVICES INC